Abstract
44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have